Clinical Trial Update: 68Ga-NOTA-RM26 PET/CT in Breast Tumor Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial investigating the PET imaging agent 68Ga-NOTA-RM26 for breast cancer; the study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 68Ga-NOTA-RM26 (NOTA-RM26)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Tumor | EARLY_Phase 1 | Status: UNKNOWN